Solanki, A. A., Schroth, C. A., Authier, C., Carlson, K., Garraway, I., Haegerich, T., … Nickols, N. G. (2022). Veterans affairs seamless phase II/III randomized trial of standard systemic therapy with or without PET-directed local therapy for oligorecurrent prostate cancer (VA STARPORT). In JOURNAL OF CLINICAL ONCOLOGY (Vol. 40).

Solanki, Abhishek A., Christopher A. Schroth, Caitlin Authier, Kimberly Carlson, Isla Garraway, Tamara Haegerich, Elizabeth Henry, et al. “Veterans affairs seamless phase II/III randomized trial of standard systemic therapy with or without PET-directed local therapy for oligorecurrent prostate cancer (VA STARPORT).” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 40, 2022.

Solanki AA, Schroth CA, Authier C, Carlson K, Garraway I, Haegerich T, et al. Veterans affairs seamless phase II/III randomized trial of standard systemic therapy with or without PET-directed local therapy for oligorecurrent prostate cancer (VA STARPORT). In: JOURNAL OF CLINICAL ONCOLOGY. 2022.

Solanki, Abhishek A., et al. “Veterans affairs seamless phase II/III randomized trial of standard systemic therapy with or without PET-directed local therapy for oligorecurrent prostate cancer (VA STARPORT).” JOURNAL OF CLINICAL ONCOLOGY, vol. 40, no. 16, 2022.

Solanki AA, Schroth CA, Authier C, Carlson K, Garraway I, Haegerich T, Henry E, Jones JA, Joseph R, Koppes T, Moghanaki D, Quek ML, Rettig M, Rhoda T, Ritter T, Robin L, Salama JK, Zacny E, Nickols NG. Veterans affairs seamless phase II/III randomized trial of standard systemic therapy with or without PET-directed local therapy for oligorecurrent prostate cancer (VA STARPORT). JOURNAL OF CLINICAL ONCOLOGY. 2022.